Navigation Links
Record Number of New Medicines in Development for Women
Date:11/12/2009

WASHINGTON, Nov. 12 /PRNewswire-USNewswire/ -- Women's Health Weekly recently reported that America's pharmaceutical research and biotechnology companies are working on nearly 1,000 life-changing medicines for diseases affecting women, according to a new report released by the Pharmaceutical Research and Manufacturers of America (PhRMA). The medicines are awaiting approval by the U.S. Food and Drug Administration or are in human clinical trials.

In the U.S., diseases that disproportionately affect women include diabetes, which has reached epidemic proportions and affects 11 million women nationwide. Autoimmune diseases strike women three times more and anxiety and depression two times more women than men. The number one killer of American women is heart disease.

The report lists 969 new medicines in development. They include 112 new treatments for breast cancer, 86 new treatments for obstetric/gynecologic conditions, 76 for asthma, 114 for autoimmune diseases, 155 for diabetes, 131 for arthritis, and 80 for Alzheimer's disease.

"America's pharmaceutical research and biotechnology companies continue making exciting progress in the search for new cures and treatments for diseases of special concern to women," said PhRMA Senior Vice President Ken Johnson in his remarks at the press briefing at the Cold Spring Harbor Laboratory on Long Island, New York. "We live in an era of medical discovery in which we understand more and more about the unique biological and behavioral differences between men and women and their respective health care needs. This knowledge is inspiring a continuing medical revolution that is bringing new hope to women around the world in the form of promising new treatments and cures."

New York Biotechnology Association Executive Director Nathan Tinker noted that incredible progress is being made by America's biotechnology and pharmaceutical research companies in developing new and more effective treatments for the wide range of diseases that affect women. "Cooperation between the country's educational facilities, research hospitals, laboratories, and innovative biopharmaceutical companies has proven critical to this success," said Tinker.

Read the original article in Women's Health Weekly.

SOURCE Pharmaceutical Research and Manufacturers of America


'/>"/>
SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Biostar Pharmaceuticals, Inc. Announces Record Third Quarter 2009 Financial Results
2. ResMed Inc. Announces Record Financial Results for the Quarter Ended September 30, 2009
3. Competitive Technologies Selects RF
4. Binder as Public Relations Agency of Record
5. Medco Delivers Record Third-Quarter 2009 GAAP Diluted EPS of $0.69; Diluted EPS Excluding Amortization of Intangible Assets of $0.75
6. Combined Pharma Event Visitor Numbers 5% Ahead of 2008 Frankfurt Record
7. Electronic Medical Record System and More
8. CryoLife Reports Record Quarterly Revenues of $28.2 Million
9. Praxis Electronic Medical Records Announces New Version 5 With Breakthrough in EHR Documentation
10. Tianyin Pharmaceutical, Co. Announces Cash Dividend to Common Shareholders - Record Date October 30, 2009
11. Aprima and MednetwoRx Partner to Provide Electronic Health Records and Remote Hosting Option to Physician Practices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... 23, 2017 LG Innotek today announced that the company ... As its sterilization performance is 1.5 times higher than the competitor,s ... rays in the range of 200 -- 280nm, allowing it to be ... destroying their DNA. LG Innotek,s product emits UV in the range ... Until ...
(Date:2/23/2017)... Research and Markets has announced the addition of the ... to 2025" report to their offering. ... The Global Cardiac Prosthetic Devices Market ... the next decade to reach approximately $8.9 billion by 2025. ... all the given segments on global as well as regional levels ...
(Date:2/23/2017)... 23, 2017 Tillotts Pharma is ... Berlin office was opened in January ... The portfolio includes Entocort ® for the treatment ... of ulcerative colitis, and VistaPrep ® for bowel ... specialty pharmaceutical company focused on the treatment of gastrointestinal ...
Breaking Medicine Technology:
(Date:2/23/2017)... , ... February 23, 2017 , ... CALNOC, the nation’s ... FACPE, will keynote their upcoming conference – Empowerment, Value and Collaboration – in Seattle, ... and CEO of the Virginia Mason Health System in Seattle since 2000. In addition ...
(Date:2/23/2017)... , ... February 23, 2017 , ... Thomas Vas-Don ... and disciplined exercise regime, the author was able to successfully recover. In “ Origin ... relevant information for various sources on the principals of massage, anatomy , ...
(Date:2/22/2017)... Raton, FL (PRWEB) , ... February 22, 2017 , ... ... primarily from deer antler velvet, announced its products are coming soon to Amazon.com, the ... Clint and Shelley Thomson as a means to develop an effective natural treatment for ...
(Date:2/22/2017)... ... February 22, 2017 , ... The National Academy of Certified ... the April 2017 testing period. NACCM, a nonprofit organization, has provided the premier ... exam is periodically re-calibrated to ensure that newly certified professionals are prepared to ...
(Date:2/22/2017)... Burlingame, CA (PRWEB) , ... February 22, 2017 ... ... of American adults with chronic conditions reported skipping doses or not filling a ... were uninsured or under-insured, rates of cost-related problems getting medications were 30-60%*. ...
Breaking Medicine News(10 mins):